Pharmacological treatment of central neuropathic pain: consensus of the Brazilian Academy of Neurology.
Rogério Adas Ayres de OliveiraAbrahão Fontes BaptistaMayara Pinheiro de SouzaLuciana Mendonça BarbosaOsvaldo José Moreira do NascimentoClarice ListikXavier MoissetManoel Jacobsen Teixeiranull nullDaniel Ciampi de AndradePublished in: Arquivos de neuro-psiquiatria (2020)
Studies that address the treatment of CNS are scarce and heterogeneous, and a significant part of the recommendations is based on experts opinions. The CNP approach must be individualized, taking into account the availability of medication, the profile of adverse effects, including addiction risk, and patients' comorbidities.